Pharmacogenomic analyses of targeting the AT-rich malaria parasite genome with AT-specific alkylating drugs

Super-AT islands, identified as unique domains in the P. falciparum genome with presumably crucial functions, offer therapeutically exploitable opportunity for new antimalarial strategies.